Technical Trend Overview and Price Movement
As of 2 June 2026, Gaudium IVF’s stock price closed at ₹114.10, down 1.98% from the previous close of ₹116.40. The stock’s intraday range was narrow, with both the high and low recorded at ₹114.10, indicating limited volatility on the day. Over the past 52 weeks, the stock has traded between ₹69.50 and ₹133.00, highlighting a wide price band and significant historical volatility.
The recent technical trend has shifted from mildly bullish to sideways, signalling a pause in upward momentum. This sideways movement suggests that investors are awaiting clearer directional cues before committing to fresh positions. The stock’s performance relative to the broader market has been underwhelming, with a one-week return of -4.76% compared to the Sensex’s -2.90%, and a one-month return of -6.05% versus the Sensex’s -3.44%. Year-to-date and longer-term returns for Gaudium IVF are not available, but the Sensex has declined by 12.85% YTD and 8.82% over the past year, indicating a challenging environment for equities.
MACD and Momentum Indicators
The Moving Average Convergence Divergence (MACD) indicator, a key momentum oscillator, currently presents a neutral to slightly bearish outlook on the weekly and monthly charts. While exact MACD values are not disclosed, the absence of a strong bullish crossover and the sideways trend suggest that momentum is waning. This aligns with the stock’s recent price stagnation and the shift away from a bullish technical posture.
The KST (Know Sure Thing) indicator, which aggregates multiple rate-of-change measures, also reflects a subdued momentum on both weekly and monthly timeframes. This further corroborates the technical narrative of a consolidating stock rather than one poised for a breakout.
RSI and Overbought/Oversold Conditions
The Relative Strength Index (RSI) on weekly and monthly charts currently shows no definitive signal, indicating that the stock is neither overbought nor oversold. This neutral RSI reading supports the sideways price action and suggests a balance between buying and selling pressures. Investors should monitor RSI closely for any divergence or movement towards extreme levels, which could presage a renewed trend.
Moving Averages and Bollinger Bands
Daily moving averages have not provided a clear directional bias recently, consistent with the sideways trend. The stock price remains close to its short-term moving averages, indicating a lack of strong directional conviction. Bollinger Bands, which measure volatility and potential price extremes, have not signalled significant expansion or contraction on weekly and monthly charts, reinforcing the view of a consolidating market.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
On-Balance Volume and Dow Theory Signals
On-Balance Volume (OBV) analysis reveals a mildly bearish sentiment on the weekly chart, suggesting that volume trends are not supporting upward price moves. This divergence between price and volume can be a warning sign of weakening demand. Meanwhile, Dow Theory assessments indicate no clear trend on weekly or monthly timeframes, reinforcing the sideways technical stance.
Mojo Score and Market Capitalisation Context
Gaudium IVF holds a Mojo Score of 51.0, categorised as a 'Hold' rating. This score reflects a balanced view of the company’s fundamentals and technicals, suggesting neither a strong buy nor a sell recommendation at present. The stock is classified as a micro-cap, which typically entails higher volatility and risk, factors that investors should weigh carefully.
Comparatively, the healthcare services sector has faced headwinds in recent months, and Gaudium IVF’s relative underperformance versus the Sensex highlights the challenges micro-cap stocks face in turbulent markets. The stock’s lack of significant positive momentum and technical upgrades means investors should exercise caution and monitor developments closely.
Is Gaudium IVF and Women Health Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Investment Implications and Outlook
Given the current technical landscape, Gaudium IVF appears to be in a consolidation phase following a period of mild bullishness. The absence of strong momentum signals from MACD, RSI, and moving averages suggests that the stock may continue to trade sideways in the near term. Investors should be mindful of the mildly bearish volume trends and the lack of clear directional cues from Dow Theory.
For those considering exposure to Gaudium IVF, the Hold Mojo Grade and micro-cap status imply a need for careful risk management. Monitoring for any breakout above the recent 52-week high of ₹133.00 or a breakdown below the 52-week low of ₹69.50 could provide clearer signals for directional trades. Additionally, keeping an eye on sectoral developments within healthcare services and broader market trends will be crucial.
In summary, while Gaudium IVF’s technical parameters have shifted to a more neutral stance, the stock remains under close watch for any signs of renewed momentum or deterioration. Investors should balance the stock’s potential with its inherent volatility and the current sideways trend before making allocation decisions.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
